# S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the Urothelium

> **NCT00055835** · PHASE2 · COMPLETED · sponsor: **SWOG Cancer Research Network** · enrollment: 7 (actual)

## Conditions studied

- Bladder Cancer
- Urethral Cancer

## Interventions

- **DRUG:** carboplatin
- **DRUG:** cisplatin
- **DRUG:** gemcitabine hydrochloride
- **DRUG:** paclitaxel
- **PROCEDURE:** neoadjuvant therapy
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00055835
- **Lead sponsor:** SWOG Cancer Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-11
- **Primary completion:** 2006-06
- **Final completion:** 2006-06
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2013-01-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00055835

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00055835, "S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the Urothelium". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00055835. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*